GPAT (GP-Act III Acquisition) Notes Receivable: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GPAT GP-Act III Acquisition Corp GPAT
17 GF Score
Price $10.91
! 2 Warning Signs
View Full Analysis

What is GP-Act III Acquisition Notes Receivable?

GP-Act III Acquisition GPAT -0.91% 17 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates GPAT with a GF Score™ of 17/100. The stock has 2 warning signs investors should review.

GP-Act III Acquisition's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

GP-Act III Acquisition Notes Receivable Related Terms

GP-Act III Acquisition Notes Receivable Historical Data

* Premium members only.

The historical data trend for GP-Act III Acquisition's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GP-Act III Acquisition Notes Receivable Chart

GP-Act III Acquisition Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

GP-Act III Acquisition Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GPAT
17GF Score
GP-Act III Acquisition Corp GPAT
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GP-Act III Acquisition Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
GP-Act III Acquisition (GPAT) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on GP-Act III Acquisition and its competitors.
Is GP-Act III Acquisition's Notes Receivable too high?
GP-Act III Acquisition's current Notes Receivable is $0.00 Mil. Overall, GP-Act III Acquisition has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does GP-Act III Acquisition's Notes Receivable compare to ALF and MBAV?
GP-Act III Acquisition's Notes Receivable of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Diversified Financial Services company?
A good Notes Receivable depends on the Diversified Financial Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on GP-Act III Acquisition and its competitors. GP-Act III Acquisition's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GP-Act III Acquisition stock overvalued right now?
GP-Act III Acquisition (GPAT) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. GP-Act III Acquisition's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For GP-Act III Acquisition (GPAT), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GP-Act III Acquisition Business Description

Address 300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
GP-Act III Acquisition Corp is a blank check company.
17GF Score

Get the complete analysis for GPAT

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.91
Price